Nurix Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-84.4M | $-90.0M | $5.7M | $15.8M |
| FY2022 | $-159.8M | $-172.1M | $12.2M | $28.1M |
| FY2023 | $-81.4M | $-89.8M | $8.4M | $33.7M |
| FY2024 | $-172.6M | $-181.9M | $9.3M | $33.9M |
| FY2025 | $-249.5M | $-263.5M | $14.0M | $38.0M |